Many clinical and patient-reported outcomes (PROs) pertaining to disease activity, disease control, and the impact on quality of life are used during the diagnosis, management, and monitoring of patients with chronic spontaneous urticaria.

Physicians face multiple challenges in the management of chronic spontaneous urticaria, including inconsistent measures of treatment success in clinical practice.

Consensus amongst physicians is needed about what constitutes treatment success.

Work towards this requires universal definitions of “remission” and “recurrence”, alongside research into predictors for these disease states. Guidance on when to step down treatment is required; and PROs should be associated with treatment targets and timepoints.